These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 1663623

  • 1. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN, Gulati A, Rahmani NH.
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN, Gulati A.
    Peptides; 1988 Feb; 9(4):771-5. PubMed ID: 2852360
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 6. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 7. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 8. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN, Gulati A.
    Pharmacology; 1988 Mar; 37(6):349-55. PubMed ID: 2854272
    [Abstract] [Full Text] [Related]

  • 9. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN, Das S, Gulati A.
    J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
    [Abstract] [Full Text] [Related]

  • 10. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN, Gulati A, Ramarao P.
    Pharmacology; 1991 Jan; 42(3):121-7. PubMed ID: 1647533
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN, Matwyshyn GA, Gudehithlu KP.
    Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats.
    Przewłocka B, Dziedzicka M, Lasoń W, Przewłocki R.
    Life Sci; 1992 Nov; 50(1):45-54. PubMed ID: 1345879
    [Abstract] [Full Text] [Related]

  • 13. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna, Reddy PL, Bhargava HN.
    Eur J Pharmacol; 1993 Apr 22; 235(1):23-30. PubMed ID: 8390939
    [Abstract] [Full Text] [Related]

  • 14. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN, Das S.
    Brain Res; 1986 Mar 19; 368(2):262-7. PubMed ID: 3008927
    [Abstract] [Full Text] [Related]

  • 15. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
    Bhargava HN, Thorat SN.
    Brain Res; 1993 Oct 15; 625(1):120-4. PubMed ID: 8242390
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
    Bhargava HN, Cao YJ.
    Peptides; 1997 Oct 15; 18(10):1629-34. PubMed ID: 9437726
    [Abstract] [Full Text] [Related]

  • 17. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L, Gu ZF, Pradhan T, Jensen RT, Maton PN.
    Am J Physiol; 1992 Mar 15; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [Abstract] [Full Text] [Related]

  • 18. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK, Barbaz B, Iyengar S, Ambrose F, Steel DJ, Neale RF, Petrack B, Bittiger H, Wood PL, Williams M.
    J Pharmacol Exp Ther; 1986 Jul 15; 238(1):178-85. PubMed ID: 3014114
    [Abstract] [Full Text] [Related]

  • 19. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
    Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.
    Pharmacol Biochem Behav; 1994 May 15; 48(1):87-91. PubMed ID: 8029307
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous modulation of TRH and opioid receptor binding in rat spinal cord after chronic naloxone administration.
    Krumins SA.
    Neuropeptides; 1988 Jan 15; 11(1):47-52. PubMed ID: 2835703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.